Wall Street analysts are divided on whether they should buy Credit Suisse – even though they find the central bank’s support for the struggling Swiss company reassuring. Shares in U.S.-listed Credit Suisse rose more than 6% in premarket trading on Thursday after it said it would borrow up to 50 billion Swiss francs ($54 billion) from the Swiss National Bank. Earlier, the central bank said it would provide liquidity to Credit Suisse if needed, saying the firm was well capitalized. Shares in Credit Suisse plunged 13.9% on Wednesday after the company’s largest investor, the National Bank of Saudi Arabia, said it could not provide more funding, raising concerns about a banking crisis in Europe. However, JPMorgan’s Roberto Henriques reiterated his overweight rating on the company following the decision to borrow from the central bank. The analyst expects the “central bank bazooka” to reassure investors over liquidity concerns and give Credit Suisse enough time to roll out a restructuring plan. CS 5D Credit Suisse 5 DAY “As markets price in the potential impact of liquidity stress, the combination of these measures should be sufficient to stem a negative move in the overall capital structure,” Henriques wrote to clients. “In our view, the coordinated action between regulators, FINMA and the central bank…underscores that while Switzerland has been one of the most proactive jurisdictions in addressing the ‘too big to fail’ Very serious and very difficult to contain, especially if we consider the global ramifications of the failure of a small U.S. bank like SVB,” he added. “While we’re clearly offside with the recent volatility at Credit Suisse, we maintain our Overweight recommendation as we believe the recent repricing has been overdone,” Henriques said. To be sure, Henriques noted that any further market volatility could hurt investor sentiment. On Thursday morning, RBC Capital Markets’ Anke Reingen reiterated his neutral rating on the bank. The analyst said stronger liquidity conditions and central bank support were positive for the Swiss company, but worried about more challenges ahead. “Regaining trust is key for CS stock. The steps taken should provide comfort that spillovers to the sector may be contained, but the situation remains uncertain,” Reingen said in a note earlier Thursday. wrote in the report. Meanwhile, Bank of America’s Alastair Ryan reiterated his buy rating, calling the joint statement from the Swiss National Bank and FINMA “clear and supportive.” Not to mention, Credit Suisse is “well capitalized.” “The recent rapid decline in Credit Suisse’s debt prices reflects the bank’s previous challenges, but also the large amount of debt outstanding, including CHF 49 billion in ‘disappearing’ bonds at the end of 2022, and the difficulty in pricing the risk of regulatory intervention .The statement from the authorities made it clear to us that Credit Suisse will continue in its current form,” Ryan wrote. “Effectively, regulatory support has been provided through this statement, but there has been no change in the structure or going concern nature of Credit Suisse. We believe this significantly reduces risk for the group from an investor perspective,” Ryan said. Elsewhere, on Wednesday, UBS analyst Daniele Brupbacher maintained his neutral rating, preferring to “remain on the sidelines” given the “challenges that need to be addressed.” Brupbacher wrote: “While we believe CS remains in execution mode trying to meet its goals, a major re-rating in the coming quarters seems unlikely given the uncertainties on many fronts.” —CNBC’s Michael Bloom contributed to this report.